Literature DB >> 27923323

Mild Hypothermia Promotes Pericontusion Neuronal Sprouting via Suppressing Suppressor of Cytokine Signaling 3 Expression after Moderate Traumatic Brain Injury.

Cheng-Cheng Zhao1, Chuan-Fang Wang1, Wei-Ping Li2, Yong Lin1, Qi-Lin Tang1, Jun-Feng Feng1, Qing Mao1, Guo-Yi Gao1, Ji-Yao Jiang1.   

Abstract

Mild therapeutic hypothermia is a candidate for the treatment of traumatic brain injury (TBI). However, the role of mild hypothermia in neuronal sprouting after TBI remains obscure. We used a fluid percussion injury (FPI) model to assess the effect of mild hypothermia on pericontusion neuronal sprouting after TBI in rats. Male Sprague-Dawley rats underwent FPI or sham surgery, followed by mild hypothermia treatment (33°C) or normothermia treatment (37°C) for 3 h. All the rats were euthanized at 7 days after FPI. Neuronal sprouting that was confirmed by an increase in growth associated protein-43 (GAP-43) expression was evaluated using immunofluorescence and Western blot assays. The expression levels of several intrinsic and extrinsic sprouting-associated genes such as neurite outgrowth inhibitor A (NogoA), phosphatase and tensin homolog (PTEN), and suppressor of cytokine signaling 3 (SOCS3) were analyzed by quantitative real-time polymerase chain reaction (RT-PCR). Our results revealed that mild hypothermia significantly increased the expression level of GAP-43 and dramatically suppressed the expression level of interleukin-6 (IL-6) and SOCS3 at 7 days after FPI in the ipsilateral cortex compared with that of the normothermia TBI group. These data suggest that post-traumatic mild hypothermia promotes pericontusion neuronal sprouting after TBI. Moreover, the mechanism of hypothermia-induced neuronal sprouting might be partially associated with decreased levels of SOCS3.

Entities:  

Keywords:  TBI; animal studies; axonal regeneration; hypothermia; neuroplasticity

Mesh:

Substances:

Year:  2017        PMID: 27923323     DOI: 10.1089/neu.2016.4759

Source DB:  PubMed          Journal:  J Neurotrauma        ISSN: 0897-7151            Impact factor:   5.269


  7 in total

1.  iTRAQ-Based Quantitative Proteomics Reveals the New Evidence Base for Traumatic Brain Injury Treated with Targeted Temperature Management.

Authors:  Shi-Xiang Cheng; Zhong-Wei Xu; Tai-Long Yi; Hong-Tao Sun; Cheng Yang; Ze-Qi Yu; Xiao-Sa Yang; Xiao-Han Jin; Yue Tu; Sai Zhang
Journal:  Neurotherapeutics       Date:  2018-01       Impact factor: 7.620

2.  Targeted Temperature Management at 36 °C Shows Therapeutic Effectiveness via Alteration of Microglial Activation and Polarization After Ischemic Stroke.

Authors:  Jong Youl Kim; Ju Hee Kim; Joohyun Park; Jin Ho Beom; Sung Phil Chung; Je Sung You; Jong Eun Lee
Journal:  Transl Stroke Res       Date:  2021-04-24       Impact factor: 6.829

3.  Xuefu zhuyu decoction improves cognitive impairment in experimental traumatic brain injury via synaptic regulation.

Authors:  Jing Zhou; Tao Liu; Hanjin Cui; Rong Fan; Chunhu Zhang; Weijun Peng; Ali Yang; Lin Zhu; Yang Wang; Tao Tang
Journal:  Oncotarget       Date:  2017-06-30

4.  Neuroprotective effects of mild hypothermia against traumatic brain injury by the involvement of the Nrf2/ARE pathway.

Authors:  Chaolong Yan; Jiannan Mao; Chenbei Yao; Yang Liu; Huiying Yan; Wei Jin
Journal:  Brain Behav       Date:  2022-07-08       Impact factor: 3.405

5.  Decreased Level of Exosomal miR-5121 Released from Microglia Suppresses Neurite Outgrowth and Synapse Recovery of Neurons Following Traumatic Brain Injury.

Authors:  Chengcheng Zhao; Yuefei Deng; Yi He; Xianjian Huang; Chuanfang Wang; Weiping Li
Journal:  Neurotherapeutics       Date:  2021-01-21       Impact factor: 6.088

Review 6.  Hypothermia: Impact on plasticity following brain injury.

Authors:  Anna C J Kalisvaart; Brittany J Prokop; Frederick Colbourne
Journal:  Brain Circ       Date:  2019-12-27

Review 7.  Microglia: A Potential Drug Target for Traumatic Axonal Injury.

Authors:  Xin Huang; Wendong You; Yuanrun Zhu; Kangli Xu; Xiaofeng Yang; Liang Wen
Journal:  Neural Plast       Date:  2021-05-20       Impact factor: 3.599

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.